Stocktoria
Bon Natural Life Ltd BON
Nasdaq · XNAS · stock · Medicinal Chemicals & Botanical Products · website · IPO 2021-06-24
Bon Natural Life Ltd statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 20.8% | 29.8% | 29.9% | 31.5% | 27.9% |
| Operating margin | -8.7% | 7.9% | 20.1% | 22.1% | 21.2% |
| Net margin | -10.7% | 1.7% | 15.6% | 20.9% | 18.0% |
| FCF margin | 0.7% | -32.4% | 21.3% | -0.7% | 15.7% |
| Return on assets | -2.3% | 0.6% | 9.9% | 16.7% | 12.6% |
| Return on equity | -3.4% | 0.9% | 12.8% | 20.7% | 17.3% |
| Debt / equity | 0.03× | 0.03× | 0.04× | 0.08× | 0.10× |
| Current ratio | 1.74 | 2.42 | 2.52 | 2.21 | 2.20 |
| Revenue growth | -21.7% | -19.2% | -1.3% | 17.3% | 39.9% |
Source: SEC EDGAR filings · CIK 0001816815 · as of 2025-09-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.